IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shepard, A. R.
Right arrow Articles by Clark, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shepard, A. R.
Right arrow Articles by Clark, A. F.
(Investigative Ophthalmology and Visual Science. 2001;42:3173-3181.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Delayed Secondary Glucocorticoid Responsiveness of MYOC in Human Trabecular Meshwork Cells

Allan R. Shepard1, Nasreen Jacobson1, John H. Fingert2, Edwin M. Stone2, Val C. Sheffield3 and Abbot F. Clark1

1 From the Alcon Research, Ltd., Fort Worth, Texas; the 2 Department of Ophthalmology, University of Iowa College of Medicine, Iowa City; and the 3 Department of Pediatrics and Howard Hughes Medical Institute, University of Iowa, Iowa City.

PURPOSE. To characterize the glucocorticoid responsiveness of the glaucoma gene MYOC (myocilin/TIGR) in cultured human trabecular meshwork (TM) cells.

METHODS. MYOC expression in two independently derived human TM cell lines was quantified by Western immunoblot analysis of protein levels and quantitative PCR analysis of mRNA levels. Promoter activity was measured indirectly with the luciferase reporter gene in a dual luciferase reporter assay.

RESULTS. Application of the synthetic glucocorticoid dexamethasone (Dex) to cultured TM cells at 100 nM resulted in a delayed (8–16 hours) induction of myocilin. The concentration dependence (median effective concentration [EC50], ~10 nM) and reversal by the glucocorticoid antagonist, RU486, implicates the glucocorticoid receptor (GR). In an interesting observation, RU486 alone acted as a partial agonist to MYOC expression. Treatment of TM cells with the protein synthesis inhibitor cycloheximide abolished the Dex induction, suggesting an indirect effect of the GR on MYOC expression. In addition, the RNA synthesis inhibitor actinomycin D also blocked Dex induction, indicating that the Dex effect was due to increased MYOC transcription. Analysis of up to 2700 nucleotides (nt) of the MYOC gene 5'-flanking region in luciferase reporter constructs showed no Dex induction, despite the presence of multiple putative glucocorticoid response element (GRE)-like half-sites in the MYOC promoter and the presence of an intact cellular GR-mediated signaling system.

CONCLUSIONS. MYOC is a delayed secondary glucocorticoid-responsive gene. Characterization of the transcription factors that mediate the secondary response will shed new light on the pathophysiology of steroid-induced ocular hypertension and glaucoma.




This article has been cited by other articles:


Home page
 Arch OphthalmolHome page
L.-Y. Jia, L. Sun, D. S. P. Fan, D. S. C. Lam, C. P. Pang, and G. H. F. Yam
Effect of Topical Ginkgo biloba Extract on Steroid-Induced Changes in the Trabecular Meshwork and Intraocular Pressure
Arch Ophthalmol, December 1, 2008; 126(12): 1700 - 1706.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. R. Shepard, N. Jacobson, J. C. Millar, I.-H. Pang, H. T. Steely, C. C. Searby, V. C. Sheffield, E. M. Stone, and A. F. Clark
Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure
Hum. Mol. Genet., March 15, 2007; 16(6): 609 - 617.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. P. Fautsch, C. K. Bahler, A. M. Vrabel, K. G. Howell, N. Loewen, W. L. Teo, E. M. Poeschla, and D. H. Johnson
Perfusion of His-Tagged Eukaryotic Myocilin Increases Outflow Resistance in Human Anterior Segments in the Presence of Aqueous Humor
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 213 - 221.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Zhang, A. F. Clark, and T. Yorio
Regulation of Glucocorticoid Responsiveness in Glaucomatous Trabecular Meshwork Cells by Glucocorticoid Receptor-{beta}
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4607 - 4616.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Grinchuk, Z. Kozmik, X. Wu, and S. Tomarev
The Optimedin Gene Is a Downstream Target of Pax6
J. Biol. Chem., October 21, 2005; 280(42): 35228 - 35237.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
D. B. Gould, L. Miceli-Libby, O. V. Savinova, M. Torrado, S. I. Tomarev, R. S. Smith, and S. W. M. John
Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma
Mol. Cell. Biol., October 15, 2004; 24(20): 9019 - 9025.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Zhang, A. F. Clark, and T. Yorio
Interactions of Endothelin-1 with Dexamethasone in Primary Cultured Human Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5301 - 5308.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
D. S. P. Fan, C. B. O. Yu, T. Y. H. Chiu, C. Y. Wong, J. S. K. Ng, C. P. Pang, and D. S. C. Lam
Ocular-Hypertensive and Anti-inflammatory Response to Rimexolone Therapy in Children
Arch Ophthalmol, December 1, 2003; 121(12): 1716 - 1721.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology